Recruiting studies: Anaplastic Malignant Meningioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
NA · 1 location(s) · Beijing Sanbo Brain Hospital · NCT04501705 NK Cell Therapy for Malignant Solid Brain Tumors
NA · 4 location(s) · Peking University Third Hospital · NCT07552233 Predictive Factors for Survival in Aggressive Meningiomas
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05793034 Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3
Phase 2 · 8 location(s) · Northwestern University · NCT02847559 Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 · 1 location(s) · Jazz Pharmaceuticals · NCT04541082 A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Phase 2 · 12 location(s) · Exelixis · NCT07428616 Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/Phase 2 · 4 location(s) · Nationwide Children's Hospital · NCT05278208

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.